US EditionResistant Hypertension: Diagnosis and Real-World Challenges
Summary by hcplive.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
All
Left
Center
Right
This was demonstrated by a study cited by Women's Health magazine, which analyzed its effects on cardiovascular and metabolic health. Read more
·Buenos Aires, Argentina
Read Full Article
Lorundrostat shows promise for uncontrolled, treatment-resistant hypertension
By Lucy Piper, medwireNews ReportermedwireNews: Lorundrostat, a selective aldosterone synthase inhibitor, shows blood pressure-lowering potential in people with uncontrolled and treatment-resistant hypertension, according to the Advance-HTN trial.This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.Read the full story on the L’Institut Servier websiteImage credit: © Kurhan / stock.adobe.com …
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
